Table 8.
The follow-up results
| Parameters | Mean (range) | |||||
|---|---|---|---|---|---|---|
| DP procedure | IMRT Procedure | |||||
| Pre-radiotherapy | Post-radiotherapy | Percentage change | Pre-radiotherapy | Post-radiotherapy | Percentage change | |
| DIL volume (cm3) | 1.73 (0.1–4.9) | 0.037 (0–0.4) | 98.83 (78.9–100) | 1.67 (0.04–5.1) | 0.24 (0–1.2) | 81.95 (38.89–100) |
| Whole prostate volume (cm3) | 37.18 (21–56) | 30.28 (18–46.9) | 18.16 (4.16–51.35) | 35.66 (20.77–62.37) | 32.41 (18–53) | 10.11 (2.4–26.32) |
| DIL ADC (10−6 mm2/s) | 894.9 (572–1420) | 1123 (823–1500) | 32.18 (0.84–111.5) | 884.3 (580–1462) | 939.2 (698–1400) | 10.35 (0.08–47.1) |
| Whole prostate ADC (10−6 mm2/s) | 1122 (869–1389) | 1072 (856–1325) | 6.81 (1.44–15.85) | 1154 (976–1421) | 1059 (723–1312) | 8.45 (1.41–20) |
| PSA level (ng/ml) | 24.86 (13.3–45) | 0.17 (.001–0.98) | 99.2 (95–99.9) | 22.22 (5.2–48) | 0.15 (.002–0.8) | 99 (93.4–100) |